Acrivon Therapeutics, Inc.(ACRV)
$1.40-0.16 (-10.26%)
ACRV
Acrivon Therapeutics, Inc. stock drug pipeline
$1.40
At close:-0.16 (-10.26%)
Want to see ACRV full AI Analyst Report?
Acrivon Therapeutics, Inc. (ACRV) Drug Pipeline
861 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Acr-2316 | Specific Advanced Solid Tumors | Phase I | Recruiting | Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors | Oct 23, 2024 | ― |
| Gemcitabine, Acr-368, Oncosignature | Endometrial Adenocarcinoma | Phase II | Recruiting | A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma | Aug 29, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Acr-2316 | Phase I | Specific Advanced Solid Tumors | Recruiting | Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors | Oct 23, 2024 | ― |
| Gemcitabine, Acr-368, Oncosignature | Phase II | Endometrial Adenocarcinoma | Recruiting | A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma | Aug 29, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Acrivon Therapeutics, Inc. (ACRV) have in its pipeline
Acrivon Therapeutics, Inc. ACRV is currently developing the following drugs: Acr-2316, Gemcitabine, Acr-368, Oncosignature. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

